Bill Chappell; Analyst; Truist Securities, Inc. Michael Lavery; Analyst; Piper Sandler & Co.

Good day, ladies and gentlemen, and welcome to the MedPace fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded. And now I'd ...

Q4 2024 Management View President Gary Yu highlighted a 5% year-over-year revenue growth in Q4 2024, marking a return to growth after a multi-year market slowdown, supported by improving momentum in ...

TTM Technologies, Inc. (NASDAQ: TTMI) ("TTM"), a leading global manufacturer of technology solutions including mission systems, radio frequency ("RF") ...

CEO Mike Morrissey highlighted significant momentum in 2024, emphasizing the company's goal of achieving $3 billion in annual cabozantinib (Cabo) revenue by 2030 and $5 billion for zanzalintinib ...

CVS Health (CVS) reports Q4 earnings on Wed. Stock is down 29.78% in past yr, up 22.72% YTD. Bullish trend but mixed signals. Analysts rate it a Buy with avg price tgt $63.67, potential 17.01% upside.

Operator Good day, ladies and gentlemen, and welcome to the Exelixis fourth quarter and fiscal year 2024 financial results ...

Coca-Cola surpasses sales targets with strong Q4 growth & optimistic FY25 guidance. Analysts highlight it as a standout bet ...

Truist lowered the firm’s price target on Inspire Medical (INSP) to $235 from $250 and keeps a Buy rating on the shares. The company’s Q4 ...

Truist lowered the firm’s price target on McDonald’s (MCD) to $340 from $342 but keeps a Buy rating on the shares. The company looks “well ...

Andrew Strelzik; Analyst; BMO Capital Markets Corp.

The January jobs report showed that hiring cooled a bit last month, but winter weather and the Los Angeles fires may have ...